The Philippine Health Research Ethics Board (PHREB) through its Committee on Standards and Accreditation, has granted a Level 2 Full Accreditation to Region 1 Health Research and Development Consortium (R1HRDC) – Ethics Review Committee (ERC) effective July 01, 2023 until June 30, 2025. As per 2022 National Ethical Guidelines for Research Involving Human Participants (NEGRIP 2022), Level 2 accredited REC reviews all types of research except clinical trials required for FDA registration of new drugs before its implementation.
Researchers who wish to have their paper/proposal to be reviewed by the committee, they may inquire through the ERC Secretary Ms. Liezel Biag-Gambol at email address: This email address is being protected from spambots. You need JavaScript enabled to view it..